|
🐜
|
Genetic insights into biological mechanisms governing human ovarian ageing
40 auth.
K. Ruth,
F. Day,
J. Hussain,
A. Martínez-Marchal,
C. Aiken,
A. Azad,
D. Thompson,
H. Abe,
J. Tarry-Adkins,
J. Martin Gonzalez,
A. Claringbould,
O. Bakker,
P. Sulem,
S. Turon,
N. Onland-Moret,
...
E. Peter Trane Hertz,
P. Timshel,
V. Shukla,
R. Borup,
K. W. Olsen,
M. Ferrer-Roda,
Y. Huang,
S. Stankovic,
P. R. Timmers,
T. Ahearn,
B. Alizadeh,
E. Naderi,
I. Andrulis,
A. Arnold,
K. Aronson,
A. Augustinsson,
S. Bandinelli,
C. Barbieri,
R. Beaumont,
H. Becher,
M. Beckmann,
S. Benonisdottir,
S. Bergmann,
M. Bochud,
Boe
|
7 |
2021 |
7
🐜
|
|
🐢
|
Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer
M. Sauer,
I. Andrulis
|
5 |
2005 |
5
🐢
|
|
🐢
|
Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer
M. Sauer,
I. Andrulis
|
5 |
2005 |
5
🐢
|
|
🐜
|
Validation study of the lambda model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women
18 auth.
C. Apicella,
J. Dowty,
G. Dite,
M. Jenkins,
Rt Senie,
M. Daly,
I. Andrulis,
E. John,
SS Buys,
Fp Li,
...
G. Glendon,
W. Chung,
H. Ozçelik,
A. Miron,
K. Kotar,
M. Southey,
W. Foulkes,
J. Hopper
|
3 |
2007 |
3
🐜
|
|
🐢
|
Identification and characterization of missense alterations in the BRCA 1 associated RING domain ( BARD 1 ) gene in breast and ovarian cancer
M. Sauer,
I. Andrulis
|
1 |
2005 |
1
🐢
|
|
🐜
|
Identification of new breast cancer predisposition genes via whole exome sequencing
21 auth.
M. Southey,
DJ Park,
F. Lesueur,
F. Odefrey,
T. Nguyen-Dumont,
F. Hammet,
S. Neuhausen,
E. John,
I. Andrulis,
G. Chenevix-Trench,
...
L. Baglietto,
F. Le Calvez-Kelm,
M. Pertesi,
A. Lonie,
B. Pope,
O. Sinilnikova,
H. Tsimiklis,
G. Giles,
J. Hopper,
S. Tavtigian,
D. Goldgar
|
0 |
2012 |
0
🐜
|
|
🦁
|
on A Study of Genetically Confirmed
I. Andrulis
|
0 |
2007 |
0
🦁
|
|
🐜
|
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
20 auth.
K. Phillips,
R. Milne,
M. Rookus,
D. Goldgar,
M. Friedlander,
S. McLachlan,
S. Buys,
A. Antoniou,
K. Birch,
M. Terry,
...
Df Easton,
P. Weideman,
M. Daly,
N. Andrieu,
E. John,
M. Hooning,
I. Andrulis,
T. Caldés,
H. Olsson,
J. Hopper
|
0 |
2012 |
0
🐜
|
